Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2014

01-12-2014 | Original Research

Perceived Discrimination, Patient Trust, and Adherence to Medical Recommendations Among Persons with Sickle Cell Disease

Authors: Carlton Haywood Jr., PhD, Sophie Lanzkron, MD, Shawn Bediako, PhD, John J. Strouse, MD, Jennifer Haythornthwaite, PhD, C. Patrick Carroll, MD, Marie Diener-West, PhD, Gladys Onojobi, MD, Mary Catherine Beach, MD, for the IMPORT Investigators

Published in: Journal of General Internal Medicine | Issue 12/2014

Login to get access

ABSTRACT

BACKGROUND

Adults with sickle cell disease (SCD) report experiencing discriminatory behavior from some healthcare providers. The impact of discrimination on health outcomes in SCD, including adherence to physician recommendations, is not known.

OBJECTIVE

Our aim was to evaluate the association between perceived discrimination from healthcare providers and nonadherence to physician recommendations among persons with SCD, and to test the potentially mediating role of patient trust.

PARTICIPANTS

Patients with SCD (age 15 years and older) participating in the Improving Patient Outcomes with Respect and Trust (IMPORT) Study.

MAIN MEASURES

Perceived discrimination from healthcare providers and reported adherence to physician recommendations were assessed by patient self-report using items from the 2001 Commonwealth Fund Health Survey. Interpersonal trust in medical professionals was assessed using the short form of the Wake Forest Trust in Medical Professionals instrument.

DESIGN

We used a cross-sectional analysis of IMPORT participant data. Multivariable Poisson regression models were used to test the independent association of discrimination with adherence and to test patient trust as a potential mediator.

KEY RESULTS

Among 273 SCD patients with complete data on all variables of interest, patients reporting experiences of discrimination in the healthcare system were 53 % more likely to also report being nonadherent to physician recommendations. Trust in medical professionals appeared to mediate the discrimination/nonadherence relationship, accounting for 50 % of the excess prevalence of nonadherence among those experiencing discrimination.

CONCLUSION

SCD patient perceptions of discriminatory experiences from healthcare providers are associated with greater nonadherence to physician recommendations, and may be a potential factor contributing to disparities in health and health quality among this patient population. Perceived discrimination appears to affect adherence behaviors through the pathway of patient trust. Improving relationships between healthcare providers and SCD patients may improve the trust that SCD patients have in medical professionals, which in turn may improve other outcomes among this underserved patient population.
Literature
1.
go back to reference Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the united states: national and state estimates. Am J Hematol. 2010;85(1):77–8.PubMed Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the united states: national and state estimates. Am J Hematol. 2010;85(1):77–8.PubMed
2.
go back to reference Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512–21.PubMedCrossRef Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512–21.PubMedCrossRef
3.
go back to reference Kaye CI, Committee on Genetics, Accurso F, et al. Newborn screening fact sheets. Pediatrics. 2006;118(3):e934–63.PubMedCrossRef Kaye CI, Committee on Genetics, Accurso F, et al. Newborn screening fact sheets. Pediatrics. 2006;118(3):e934–63.PubMedCrossRef
4.
go back to reference Steinberg MH. Disorders of Hemoglobin: genetics, Pathophysiology, and Clinical Management. 2nd ed. New York: Cambridge University Press; 2009:826.CrossRef Steinberg MH. Disorders of Hemoglobin: genetics, Pathophysiology, and Clinical Management. 2nd ed. New York: Cambridge University Press; 2009:826.CrossRef
5.
go back to reference Lanzkron S, Haywood C Jr, Fagan PJ, Rand CS. Examining the effectiveness of hydroxyurea in people with sickle cell disease. J Health Care Poor Underserved. 2010;21(1):277–86.PubMedCrossRef Lanzkron S, Haywood C Jr, Fagan PJ, Rand CS. Examining the effectiveness of hydroxyurea in people with sickle cell disease. J Health Care Poor Underserved. 2010;21(1):277–86.PubMedCrossRef
6.
go back to reference Candrilli SD, O’Brien SH, Ware RE, Nahata MC, Seiber EE, Balkrishnan R. Hydroxyurea adherence and associated outcomes among medicaid enrollees with sickle cell disease. Am J Hematol. 2011;86(3):273–7.PubMedCrossRef Candrilli SD, O’Brien SH, Ware RE, Nahata MC, Seiber EE, Balkrishnan R. Hydroxyurea adherence and associated outcomes among medicaid enrollees with sickle cell disease. Am J Hematol. 2011;86(3):273–7.PubMedCrossRef
8.
go back to reference Maxwell K, Streetly A, Bevan D. Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. BMJ. 1999;318(7198):1585–90.PubMedCentralPubMedCrossRef Maxwell K, Streetly A, Bevan D. Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. BMJ. 1999;318(7198):1585–90.PubMedCentralPubMedCrossRef
9.
go back to reference Alleyne J, Thomas VJ. The management of sickle cell crisis pain as experienced by patients and their carers. J Adv Nurs. 1994;19(4):725–32.PubMedCrossRef Alleyne J, Thomas VJ. The management of sickle cell crisis pain as experienced by patients and their carers. J Adv Nurs. 1994;19(4):725–32.PubMedCrossRef
10.
go back to reference Lattimer L, Haywood C Jr, Lanzkron S, Ratanawongsa N, Bediako SM, Beach MC. Problematic hospital experiences among adult patients with sickle cell disease. J Health Care Poor Underserved. 2010;21(4):1114–23.PubMedCentralPubMed Lattimer L, Haywood C Jr, Lanzkron S, Ratanawongsa N, Bediako SM, Beach MC. Problematic hospital experiences among adult patients with sickle cell disease. J Health Care Poor Underserved. 2010;21(4):1114–23.PubMedCentralPubMed
11.
go back to reference Haywood C Jr, Beach MC, Lanzkron S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc. 2009;101(10):1022–33.PubMed Haywood C Jr, Beach MC, Lanzkron S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc. 2009;101(10):1022–33.PubMed
12.
go back to reference Haywood C Jr, Lanzkron S, Ratanawongsa N, et al. The association of provider communication with trust among adults with sickle cell disease. J Gen Intern Med. 2010;25(6):543–8.PubMedCentralPubMedCrossRef Haywood C Jr, Lanzkron S, Ratanawongsa N, et al. The association of provider communication with trust among adults with sickle cell disease. J Gen Intern Med. 2010;25(6):543–8.PubMedCentralPubMedCrossRef
13.
go back to reference Haywood C Jr, Lanzkron S, Ratanawongsa N, Bediako SM, Lattimer-Nelson L, Beach MC. Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care. J Hosp Med. 2010;5(5):289–94.PubMedCentralPubMedCrossRef Haywood C Jr, Lanzkron S, Ratanawongsa N, Bediako SM, Lattimer-Nelson L, Beach MC. Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care. J Hosp Med. 2010;5(5):289–94.PubMedCentralPubMedCrossRef
14.
go back to reference Collins KS, Hughes DL, Doty MM, et al. Diverse Communities, Common Concerns: assessing Health Care Quality for Minority Americans. New York: The Commonwealth Fund; 2002. Collins KS, Hughes DL, Doty MM, et al. Diverse Communities, Common Concerns: assessing Health Care Quality for Minority Americans. New York: The Commonwealth Fund; 2002.
15.
go back to reference Johnson RL, Saha S, Arbelaez JJ, Beach MC, Cooper LA. Racial and ethnic differences in patient perceptions of bias and cultural competence in health care. J Gen Intern Med. 2004;19(2):101–10.PubMedCentralPubMedCrossRef Johnson RL, Saha S, Arbelaez JJ, Beach MC, Cooper LA. Racial and ethnic differences in patient perceptions of bias and cultural competence in health care. J Gen Intern Med. 2004;19(2):101–10.PubMedCentralPubMedCrossRef
16.
go back to reference Dugan E, Trachtenberg F, Hall MA. Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res. 2005;5:64.PubMedCentralPubMedCrossRef Dugan E, Trachtenberg F, Hall MA. Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res. 2005;5:64.PubMedCentralPubMedCrossRef
17.
go back to reference Behrens T, Taeger D, Wellmann J, Keil U. Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med. 2004;43(5):505–9.PubMed Behrens T, Taeger D, Wellmann J, Keil U. Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med. 2004;43(5):505–9.PubMed
18.
go back to reference Cummings P. Methods for estimating adjusted risk ratios. Stata J. 2009;9(2):175–96. Cummings P. Methods for estimating adjusted risk ratios. Stata J. 2009;9(2):175–96.
19.
go back to reference Coutinho LM, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica. 2008;42(6):992–8.PubMedCrossRef Coutinho LM, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica. 2008;42(6):992–8.PubMedCrossRef
20.
go back to reference Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438–45.PubMedCrossRef Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438–45.PubMedCrossRef
21.
go back to reference Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.PubMedCrossRef Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.PubMedCrossRef
22.
go back to reference StataCorp. Stata Statistical Software: release 13. College Station: StataCorp LP; 2013. StataCorp. Stata Statistical Software: release 13. College Station: StataCorp LP; 2013.
23.
go back to reference Cuffee YL, Hargraves JL, Rosal M, et al. Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension. Am J Public Health. 2013;103:e55–62.PubMedCentralPubMedCrossRef Cuffee YL, Hargraves JL, Rosal M, et al. Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension. Am J Public Health. 2013;103:e55–62.PubMedCentralPubMedCrossRef
24.
go back to reference Elder K, Ramamonjiarivelo Z, Wiltshire J, et al. Trust, medication adherence, and hypertension control in southern African American men. Am J Public Health. 2012;102(12):2242–5.PubMedCrossRef Elder K, Ramamonjiarivelo Z, Wiltshire J, et al. Trust, medication adherence, and hypertension control in southern African American men. Am J Public Health. 2012;102(12):2242–5.PubMedCrossRef
25.
26.
go back to reference McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50.PubMedCentralPubMedCrossRef McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50.PubMedCentralPubMedCrossRef
27.
go back to reference Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992;146(6):1559–64.PubMedCrossRef Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992;146(6):1559–64.PubMedCrossRef
28.
go back to reference Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149(2 Pt 2):S69–76. discussion S77-8.PubMedCrossRef Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149(2 Pt 2):S69–76. discussion S77-8.PubMedCrossRef
29.
go back to reference Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract. 2009;15(1):34–44.PubMedCrossRef Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract. 2009;15(1):34–44.PubMedCrossRef
30.
go back to reference Balkrishnan R, Jayawant SS. Medication adherence research in populations: measurement issues and other challenges. Clin Ther. 2007;29(6):1180–3.PubMedCrossRef Balkrishnan R, Jayawant SS. Medication adherence research in populations: measurement issues and other challenges. Clin Ther. 2007;29(6):1180–3.PubMedCrossRef
31.
go back to reference Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2(6):757–64.PubMedCrossRef Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2(6):757–64.PubMedCrossRef
32.
go back to reference Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074,90. discussion 1073.CrossRef Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074,90. discussion 1073.CrossRef
33.
go back to reference Zempsky WT. Treatment of sickle cell pain: fostering trust and justice. JAMA. 2009;302(22):2479–80.PubMedCrossRef Zempsky WT. Treatment of sickle cell pain: fostering trust and justice. JAMA. 2009;302(22):2479–80.PubMedCrossRef
34.
go back to reference Elander J, Beach MC, Haywood C. Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethn Health. 2011;16(4–5):405–21.PubMedCentralPubMedCrossRef Elander J, Beach MC, Haywood C. Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethn Health. 2011;16(4–5):405–21.PubMedCentralPubMedCrossRef
Metadata
Title
Perceived Discrimination, Patient Trust, and Adherence to Medical Recommendations Among Persons with Sickle Cell Disease
Authors
Carlton Haywood Jr., PhD
Sophie Lanzkron, MD
Shawn Bediako, PhD
John J. Strouse, MD
Jennifer Haythornthwaite, PhD
C. Patrick Carroll, MD
Marie Diener-West, PhD
Gladys Onojobi, MD
Mary Catherine Beach, MD
for the IMPORT Investigators
Publication date
01-12-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-2986-7

Other articles of this Issue 12/2014

Journal of General Internal Medicine 12/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.